Febrifugine is the active component of the Chinese herb Chang Shan (Dichroa febrifuga Lour.) 1, 2 , which has been used for treating malaria-induced fever for about 2,000 years. Halofuginone (HF), the halogenated derivative of febrifugine, has been tested in clinical trials for potential therapeutic applications in cancer and fibrotic disease [3] [4] [5] [6] . Recently, HF was reported to inhibit T H 17 cell differentiation by activating the amino acid response pathway 7 , through inhibiting human prolyl-transfer RNA synthetase (ProRS) to cause intracellular accumulation of uncharged tRNA 8, 9 . Curiously, inhibition requires the presence of unhydrolysed ATP. Here we report an unusual 2.0 Å structure showing that ATP directly locks onto and orients two parts of HF onto human ProRS, so that one part of HF mimics bound proline and the other mimics the 39 end of bound tRNA. Thus, HF is a new type of ATP-dependent inhibitor that simultaneously occupies two different substrate binding sites on ProRS. Moreover, our structure indicates a possible similar mechanism of action for febrifugine in malaria treatment. Finally, the elucidation here of a two-site modular targeting activity of HF raises the possibility that substrate-directed capture of similar inhibitors might be a general mechanism that could be applied to other synthetases.
ProRS is a member of the aminoacyl-tRNA synthetase family of enzymes that activate amino acids for protein synthesis through formation of aminoacyl adenylates (AA-AMP) and subsequent transfer of the activated amino acids to the 39 ends of the cognate tRNAs. Because of their crucial role in protein synthesis, inhibition halts the growth and suppresses the viability of all cell types. Consequently, aminoacyl-tRNA synthetases are attractive targets for discovering types of drugs such as antibiotics and suppressors of cell hyperproliferation 10, 11 . Many tRNA synthetase inhibitors mimic AA-AMPs; the AA-AMP mimics directly occupy and block the active site for ATP and amino acid and compete out the substrate ATP. By contrast, ATP was reported to be essential for HF binding to ProRS 8 . This ATP dependence suggests that HF binds to ProRS through a different mechanism and not as a mimetic of Pro-AMP. Thus, understanding how HF inhibits human ProRS is of great interest.
In its simplest description, HF is composed of a hydroxypiperidine ring joined by bridging atoms to a double-ring halogenated 4quinazolinone ( Fig. 1a ). To clarify the mechanism of inhibition of HF, we cloned and expressed human ProRS and were able to obtain cocrystals with a non-hydrolysable ATP analogue ((adenosine 59-(b, c-imido)triphosphate) (ATP a )) and HF, which diffracted to 2.0 Å resolution (Supplementary Table 1 ). The structure was solved by molecular replacement using Thermus thermophilus ProRS as template. The asymmetric unit contained two ProRS molecules that formed a homodimer ( Fig. 1b ), as also seen in gel filtration experiments (data not shown). Each subunit encoded an amino-terminal catalytic domain characteristic of a class II tRNA synthetase, an anticodon-binding domain and a carboxy-terminal zinc-binding domain (Fig. 1b ). In the two catalytic domains of the ProRS homodimer, HF and ATP a were bound to the active site for Pro-AMP formation (Fig. 1b, c) . ATP a was located at the canonical ATP-binding pocket of class II aminoacyl-tRNA synthetases 12 . Three hydrogen bonds contributed by Thr 1164 and Thr 1276 and hydrophobic stacking of Phe 1167 stabilized the adenosine group ( Supplementary Fig. 2 ). The ribose moiety was bound by three hydrogen bonds with Gln 1237, Thr 1240 and Arg 1278. The hydrogen bonds from Arg 1152 and Arg 1163 contributed to stabilizing the a-, band c-phosphate groups of ATP a (Supplementary Fig. 2 ), which form a cap over the HF-binding pocket (Fig. 1c ). These extensive hydrophilic and hydrophobic interactions positioned the ATP in a 'U'-like bent conformation with the a-phosphate group exposed at the bottom of the U shape. Superposition of the catalytic domains of human ProRS with that of the previously determined structure of T. thermophilus ProRS showed that the conformation and location of ATP was the same ( Supplementary Fig. 3 ), with the aphosphate group poised for proline activation. In the human ProRS-HF-ATP a ternary complex, the a-phosphate group is proximal to the hydroxypiperidine ring of HF and forms two hydrogen bonds with its hydroxyl group ( Fig. 2a, b ). It also forms an additional hydrogen bond with the keto group in the bridge between the piperidine ring and the quinazolinone moiety of HF ( Fig. 2a, b ). These direct hydrogen-bond interactions may enable ATP to lock onto and orient HF.
In addition to the interactions with ATP, ProRS itself forms seven hydrogen bonds and several hydrophobic contacts with each moiety of HF ( Fig. 2a, b) . Thus, the pocket for the HF piperidine ring, built by Thr 1121, Glu 1123, Trp 1169, Glu 1171, His 1173, Thr 1240, His 1242 and Ser 1272 ( Fig. 2c ), has both hydrophobic and hydrophilic character. These residues are highly conserved among eukaryotic ProRS ( Supplementary Fig. 4 ), and were found to be also important for proline recognition in the structure of T. thermophilus eukaryotic-like ProRS with proline ( Fig. 2d) 13 . Overlay of the catalytic domains of human and T. thermophilus ProRS structures showed the piperidine ring of HF bound to the same site as proline ( Fig. 2e ). In particular, the 
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orientations of the proline pyrrolidine ring and of the HF piperidine ring, and the locations of nitrogen and oxygen atoms, are similar. Thus, the HF piperidine ring structurally mimics a proline-like group, and would directly compete with proline and block proline activation. The proline mimic mechanism is consistent with the observation that HF or febrifugine derivatives with piperidine ring modifications are unable to bind to the proline-binding pocket and therefore are rendered unable to inhibit or bind to ProRS or affect cell function (for example, MAZ1310 ref. 8) . In contrast, derivatives that replaced the piperidine ring by the pyrrolidine ring of proline retained similar or superior biological activity 14 .
The halogenated 4-quinazolinone group is buried in a pocket mainly composed of Leu 1087, Phe 1097, Val 1101, Pro 1120, Thr 1121 and Arg 1152 ( Fig. 2a, f) . In addition to the hydrogen bonds between Arg 1152 and the quinazoline nitrogen atom, the quinazolinone group was mainly stabilized by hydrophobic contacts, particularly by the hydrophobic stack effect from Phe 1097 ( Fig. 2a, f) . Threonyl-tRNA synthetase (ThrRS) also belongs to class II aminoacyl-tRNA synthetases, and it is most similar to ProRS. Arg 1152 and Phe 1097 of ProRS are conserved in class II synthetases. The corresponding residues Arg 363 and Tyr 313 in the structure of Escherichia coli ThrRS were found to flank the two sides of the adenosine A76 of tRNA Thr and thus play crucial roles in CCA 39-end binding (Fig. 2g) 15 . In addition to these two residues, other parts of the A76 adenosine pocket are also quite similar to the quinazolinone group binding pocket in the ProRS structure ( Fig. 2g ). Overlay of the ProRS and ThrRS structures by aligning the conserved 7-strand b-sheet core of their catalytic domains showed that the quinazolinone group of HF bound to the same position as bound A76, and with a similar orientation and side-chain contacts (Fig. 2h ). This structural similarity indicates that the quinazolinone group of HF binds to ProRS by using a strategy of mimicking the terminal adenosine of the tRNA substrate. Thus, in contrast to the single-site and conventional AA-AMP mimics, HF is a dual-site inhibitor by virtue of simultaneously occupying two active site pockets, the proline binding pocket and the binding pocket for the 39 end of the tRNA ( Supplementary Fig. 1 ).
We used our crystal structure of the ProRS-ATP-HF complex to further dissect the mechanism of action of HF. Earlier work by other groups showed that HF specifically inhibits overall aminoacylation of tRNA Pro and that binding of HF to ProRS is greatly enhanced by ATP 8 (the level of HF binding, in the absence of ATP, was unknown and presumably weak). According to our structure, HF is 'two-headed' and, with bound ATP, uses the piperidine ring to block the proline binding site and the quinazolinone group to block the site for docking the 39 end of tRNA Pro . We designed experiments to probe the function of each site, the site for adenylate formation/binding and the site for docking the 39 end of tRNA. In addition to HF, we used another inhibitor, Pro-SA (59-O-(N-(L-prolyl)-sulphamoyl-adenosine), as a comparator. Pro-SA is a tight-binding non-reactive adenylate analogue of Pro-AMP 16 .
We first determined that the thermal melting of ProRS was barely affected by either proline or ATP a . In contrast, in the presence of HF the melting curve was shifted to a higher temperature by about 10 uC by HF alone, and by about 18 uC with HF plus ATP a (Fig. 3a) . These data show that HF binds even in the absence of ATP, and also confirm that HF binds much tighter in the presence of ATP. Not surprisingly, the largest thermal shift was obtained with Pro-SA.
To probe the adenylate-formation site, we studied the first step of aminoacylation, which is the activation of proline by ProRS to form a tightly bound Pro-AMP adenylate complex and release of pyrophosphate (PPi). This reaction step is ProRS 1 Pro 1 ATP R ProRS-Pro-AMP 1 PPi.
The conventional proline-dependent ATP-PPi exchange reaction was used to investigate this reaction. As expected, both Pro-SA and HF were potent inhibitors of this reaction in a dose-dependent fashion, with Pro-SA being more effective (Fig. 3b ). This result is consistent with the thermal melting data of Fig. 3a showing the tighter binding of Pro-SA, and with our X-ray crystal structure showing the docking of one 'head'of HF at the site for the prolyl moiety of Pro-AMP.
Next, we investigated the ability of HF to mimic the docking of A76 of tRNA Pro to ProRS. For this purpose we studied the effect of HF on the relatively stable preformed ProRS-Pro-AMP complex, isolated using a column. Because binding of tRNA to tRNA synthetases is generally associated with conformational changes that mobilize the active site for transfer of the activated amino acid to A76, we reasoned that binding of the A76-mimicking quinazolinone group of HF would result in an abortive transfer and thereby release Pro-AMP from ProRS. Accordingly, the ProRS-Pro-AMP complex was incubated separately with Pro-SA (which should not have access to the A76 site) and with HF (without ATP). As expected, Pro-SA caused some reduction in the bound Pro-AMP, which is attributed to an exchange on the enzyme between bound Pro-AMP and Pro-SA. In contrast, free HF, while having a much lower affinity than Pro-SA for ProRS, completely released Pro-AMP from the complex (Fig. 3c ).This result supports the conclusion (from our X-ray structure) that HF also mimics A76 of tRNA.
HF is a halogenated derivative of febrifugine, which is the bioactive constituent in the Chang Shan herb that has long been used to treat malaria. The ProRS binding sites of both human and the malaria AlaRS. c, HF mobilizes the release of Pro-AMP from ProRS. The ProRS-[ 3 H]Pro-AMP complex was prepared on ice and then isolated on a column and for 10 min was left untreated, or exposed to HF, or exposed to Pro-SA, respectively. The complex was then re-run on the column and the amount of bound 
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parasite Plasmodium falciparum are highly similar ( Supplementary  Fig. 4 ). With that in mind, using our ATP-dependent docking of HF to human ProRS as a template, we were able to show the potential for febrifugine docking to P. falciparum ProRS (Fig. 4) . Thus, our analysis suggests malarial ProRS may also be the target of febrifugine. This possibility could also explain why the lethal effect of febrifugine on P. falciparum in culture is reversed by proline 8 .
Interestingly, in addition to the inhibition of amino acid activation by mimics of AA-AMP (including the 'operational' mimic pseudomonic acid (mupirocin) 17 ), the ATP-dependent two-site HF inhibition mechanism reported here, and the single-site tRNA-dependent editing-site-trapping mechanism reported earlier 18 , illustrate two entirely different and unusual mechanisms for substrate participation in capture of an inhibitor ( Supplementary Fig. 5 ). In addition, by substitution of the piperidine ring with other amino acid mimics, dualsite inhibitors could in principle be designed for other aminoacyl-tRNA synthetases.
METHODS SUMMARY
Human ProRS was overexpressed in E. coli and purified by fast protein liquid chromatography. The protein-ligand complex was generated by mixing the protein with 3 mM halofuginone, 5 mM ATP analogue adenosine 59-(b,c-imido)triphosphate, 5 mM MgCl 2 and 5 mM b-mercaptoethanol. Crystals were obtained by the sitting-drop vapour-diffusion method, and diffraction data were collected using a single flash-frozen crystal. The ProRS-ligand complex structure was determined by the molecular replacement method, using the structure of T. thermophilus ProRS (PDB code 1HC7) as the searching model. Standard refinement procedures were performed to get the final model. The ATP-pyrophosphate exchange was as described 21 and the ProRS-Pro-AMP complex was isolated with a desalting column. Results were analysed with GraphPad Prism software. 
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